These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35442519)

  • 1. Digitally enabled hemovigilance allows real time response to transfusion reactions.
    Villamin C; Bates T; Mescher B; Benitez S; Martinez F; Knopfelmacher A; Correa Medina M; Klein K; Dasgupta A; Jaffray DA; Porter C; Tereffe W; Gallardo L; Kelley J
    Transfusion; 2022 May; 62(5):1010-1018. PubMed ID: 35442519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and implementation of a hemovigilance program at a university veterinary teaching hospital.
    Haines JM; Ngwenyama TR; Martin LG; Wardrop KJ
    J Vet Emerg Crit Care (San Antonio); 2022 May; 32(3):315-321. PubMed ID: 35001463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trend towards reduction of transfusion reactions using prestorage leukocyte-reduced and pooled whole blood-derived platelets and cost savings compared with poststorage whole blood-derived random platelets as evidenced by real-time hemovigilance.
    Park N; Correa Medina M; Martinez F; Throssel M; Dasgupta A; Knopfelmacher A; Villamin C; Rivas S; Tomczak N; Garg S; Layton L; Klein K
    Lab Med; 2024 May; 55(3):251-254. PubMed ID: 38175635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012.
    Harvey AR; Basavaraju SV; Chung KW; Kuehnert MJ
    Transfusion; 2015 Apr; 55(4):709-18. PubMed ID: 25371300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Retrospective Analysis of Transfusion Reactions at a Tertiary Care Center: An Institutional Hemovigilance Study.
    Korkmaz E; Korkut S; Akkoyun N
    J Contin Educ Nurs; 2021 Dec; 52(12):581-588. PubMed ID: 34870535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of acute transfusion reactions in a teaching hospital of Sikkim: A hemovigilance initiative.
    Sharma DK; Datta S; Gupta A
    Indian J Pharmacol; 2015; 47(4):370-4. PubMed ID: 26285707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion-related adverse reactions: Data from the National Healthcare Safety Network Hemovigilance Module - United States, 2013-2018.
    Kracalik I; Mowla S; Basavaraju SV; Sapiano MRP
    Transfusion; 2021 May; 61(5):1424-1434. PubMed ID: 33880771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion Reactions and Adverse Events.
    Abdallah R; Rai H; Panch SR
    Clin Lab Med; 2021 Dec; 41(4):669-696. PubMed ID: 34689973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion-Associated Adverse Events: A Case Report of Nurse Hemovigilance and Recognition of Respiratory Distress.
    Lea NC; Gibbs K; Johnson C; Lam A; Wuestner E; Hui SR
    J Infus Nurs; 2022 Sep-Oct 01; 45(5):264-269. PubMed ID: 36112874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardized reporting of pulmonary transfusion complications: Development of a model reporting form and flowchart.
    van Wonderen SF; Peters AL; Grey S; Rajbhandary S; de Jonge LL; Andrzejewski C; Narayan S; Wiersum-Osselton JC; Vlaar APJ
    Transfusion; 2023 Jun; 63(6):1161-1171. PubMed ID: 37060282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemovigilance and patient safety: analysis of immediate transfusion reactions in elderly.
    Sobral PADS; Göttems LBD; Santana LA
    Rev Bras Enferm; 2020; 73(suppl 3):e20190735. PubMed ID: 33084830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed hemolytic transfusion reaction in the French hemovigilance system.
    Rieux C; Brittenham G; Bachir D; De Meyer E; Boudjedir K;
    Transfus Clin Biol; 2019 May; 26(2):109-111. PubMed ID: 30910456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provider trends in paediatric and adult transfusion reaction reporting.
    Vossoughi S; Parker-Jones S; Schwartz J; Stotler B
    Vox Sang; 2019 Apr; 114(3):232-236. PubMed ID: 30734306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thirty years of hemovigilance - Achievements and future perspectives.
    Vuk T; Politis C; Laspina S; Lozano M; Haddad A; de Angelis V; Garraud O;
    Transfus Clin Biol; 2023 Feb; 30(1):166-172. PubMed ID: 36216308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of mandating a dedicated hemovigilance nurse and objectification of 'imputability' levels. Experience from a hospital-based blood centre in India.
    Dhiman Y; Raturi M; Kala M; Kusum A
    Transfus Clin Biol; 2023 Feb; 30(1):96-102. PubMed ID: 36162622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective evaluation of adverse transfusion reactions following blood product transfusion from a tertiary care hospital: A preliminary step towards hemovigilance.
    Kumar P; Thapliyal R; Coshic P; Chatterjee K
    Asian J Transfus Sci; 2013 Jul; 7(2):109-15. PubMed ID: 24014939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion-related errors and associated adverse reactions and blood product wastage as reported to the National Healthcare Safety Network Hemovigilance Module, 2014-2022.
    Chavez Ortiz JL; Griffin I; Kazakova SV; Stewart PB; Kracalik I; Basavaraju SV
    Transfusion; 2024 Apr; 64(4):627-637. PubMed ID: 38476028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion reaction reporting in the era of hemovigilance: where form meets function.
    Dunbar NM; Walsh SJ; Maynard KJ; Szczepiorkowski ZM
    Transfusion; 2011 Dec; 51(12):2583-7. PubMed ID: 21745209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of acute transfusion reactions to platelets in hospitalized pediatric patients based on the US hemovigilance reporting system.
    Li N; Williams L; Zhou Z; Wu Y
    Transfusion; 2014 Jun; 54(6):1666-72. PubMed ID: 24410992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the National Healthcare Safety Network Hemovigilance Module for transfusion-related adverse reactions in the United States.
    Edens C; Haass KA; Cumming M; Osinski A; O'Hearn L; Passanisi K; Eaton L; Visintainer P; Savinkina A; Kuehnert MJ; Basavaraju SV; Andrzejewski C
    Transfusion; 2019 Feb; 59(2):524-533. PubMed ID: 30427540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.